Physician profile
Mina Guerges
NPI 1437596889
$19,207.82
in general payments reported to CMS, 2019-2025
28 companies · $1,020 in 2025
The $1,020 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.67 · 2020: $993 · 2021: $2,760 · 2022: $9,356 · 2023: $2,940 · 2024: $2,047 · 2025: $1,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,846 · Long Term Medical Supply Or Device Loan: $1,003 · Travel and Lodging: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,845.55 |
| Long Term Medical Supply Or Device Loan | $1,002.97 |
| Travel and Lodging | $158.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $6,632.37 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $2,233.11 | 2021-2025 | Endurant Iis, Heli-Fx Endoanchor System, Hawkone |
| Cardiovascular Systems INC. | $2,160.61 | 2020-2022 | |
| Integra Lifesciences Corporation | $1,087.52 | 2023-2025 | Amnioexcel, Integra, Primatrix |
| Endologix LLC | $1,065.63 | 2021-2024 | Torus Stent Graft System, Endocross Device |
| Medtronic Vascular, INC. | $963.88 | 2019-2020 | |
| Angiodynamics, INC. | $616.13 | 2022-2023 | Venacure 1470 Pro |
| W. L. Gore & Associates, INC. | $466.73 | 2021-2024 | Gore Viabahn Endoprosthesis With Heparin, Gore Viabahn Endoprosthesis, Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Cook Medical LLC | $447.85 | 2021-2024 | Zenith Spiral-Z |
| Bard Peripheral Vascular, INC. | $430.03 | 2021-2024 | Rotarexs 6 F X 135 Cm, Crosser Iq, Halo One Thin-Walled Guiding Sheath |
| Limflow INC. | $377.99 | 2023 | Limflow System |
| Shockwave Medical, INC | $377.09 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kerecis Limited | $333.84 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Abbott Laboratories | $300.80 | 2023-2025 | Diamondback Peripheral, Esprit, Supera |
| Silk Road Medical, INC. | $289.25 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cagent Vascular INC | $258.11 | 2023 | Serrantor |
| Globus Medical, INC. | $246.80 | 2022-2023 | Mars Anterior Retractor |
| Stryker Corporation | $175.59 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Clottriever Bold Catheter |
| Becton, Dickinson and Company | $142.65 | 2024 | Lutonix Drug Coated Balloon |
| Kci USA, INC. | $125.00 | 2022 | |
| Penumbra, INC. | $124.99 | 2024 | Indigo System |
| Surmodics, INC. | $109.11 | 2024 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Pounce LP Thrombectomy |
| Boston Scientific Corporation | $82.81 | 2021 | |
| Convatec INC. | $61.00 | 2024 | |
| Biocomposites INC | $36.91 | 2025 | Stimulan |
| Lemaitre Vascular, INC. | $27.44 | 2025 | Artegraft Vascular Graft |
| Janssen Pharmaceuticals, INC | $18.88 | 2023 | Xarelto |
| Depuy Synthes Sales INC. | $15.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mina Guerges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.